Expression patterns of ANRIL and GAS-5 and genetic variants in breast cancer
- 6 March 2026
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 466
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Long Non-Coding RNAs as Potential Diagnostic and Prognostic Biomarkers in Breast Cancer: Progress and ProspectsFrontiers in Oncology, 2021
- Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated ReviewCancers, 2021
- Long Noncoding RNA GAS5 in Breast Cancer: Epigenetic Mechanisms and Biological FunctionsInternational Journal of Molecular Sciences, 2021
- Influence of a 5-bp Indel Polymorphism at Promoter of the GAS5 lncRNA and Risk of Breast CancerAsian Pacific Journal of Cancer Prevention, 2020
- The Growth-Arrest-Specific (GAS)-5 Long Non-Coding RNA: A Fascinating lncRNA Widely Expressed in CancersNon-Coding RNA, 2019
- Long Non-coding RNA ANRIL in the Nucleus Associates With Periostin Expression in Breast CancerFrontiers in Oncology, 2019
- A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast CancerClinical Breast Cancer, 2019
- Expression Profile of Long Noncoding RNAs, lnc-Cox2, and HOTAIR in Rheumatoid Arthritis PatientsJournal of Interferon & Cytokine Research, 2019
- Eighth Edition of the AJCC Cancer Staging Manual: Breast CancerAnnals of Surgical Oncology, 2018
- Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian womenGene, 2016